DIA Biosimilars 2013

Bend Research

Catalent, Bend Research to provide integrated solutions for oral controlled-release technologies

Monday, June 25, 2012 10:17 AM

Catalent Pharma Solutions of Somerset, N.J., and Bend Research of Bend, Ore., have entered into an agreement to provide integrated solutions for pharmaceutical companies seeking to develop and manufacture specialized multiparticulate oral controlled-release products.

More... »

Cenduit: Now with Patient Reminders

Bend Research launches biotherapeutics development initiative

Monday, March 26, 2012 10:52 AM

Bend Research, an independent drug-formulation development and manufacturing company based in Bend, Ore., has launched an initiative to expand its scientific and engineering expertise into biotherapeutics.

More... »

CRF Health – eCOA Forum

Bend Research signs licensing agreement with Merck

Wednesday, November 16, 2011 02:49 PM

Bend Research, an independent drug-formulation development and manufacturing company, has entered into a licensing agreement with Merck, through a subsidiary.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs